Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

ACH-3422 shows low potential for mitochondrial toxicity

March 17, 2015

Anti-AMHR2 antibody increases the efficacy of conventional first-line chemotherapy

March 17, 2015

Bendavia fails to reduce infarct size in first-time STEMI patients

March 16, 2015

CPE gene null mutation linked to severe obesity and other disorders

March 16, 2015

Epic's CTC technology reveals actionable liquid biopsy biomarkers for prostate and bladder cancer

March 16, 2015

Thyroid hormone receptor activation induces white adipose tissue conversion

March 13, 2015

GlaxoSmithKline describes second-generation HIV-1 maturation inhibitor

March 13, 2015

HM-10560A found safe in growth hormone deficiency patients

March 13, 2015

Phase I results reported on novel peptide deformylase inhibitor, IDP-73152 mesylate

March 13, 2015

Canagliflozin provides greater reduction in A1C and body weight than sitagliptin

March 13, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 20, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 20, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...